According to a recent study titled ‘Electrophysiology Market Size By Product (Electrophysiology Ablation Catheters {Radiofrequency, Cryoablation, Laser}, Electrophysiology Diagnostic Catheters {Conventional, Advanced, Ultrasound}, Electrophysiology Laboratory Devices), By Indication (Atrial Fibrillation, Ventricular Tachycardia, Atrial Tachycardia, Atrial Flutter, WOLFF-Parkinson-White (WPW) Syndrome, Atrioventricular Nodal Reentry Tachycardia ), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Ukraine, Poland, Switzerland, Belgium, Greece, Czech Republic, Netherlands, Sweden, China, Japan, India, Australia, South Korea, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Kuwait, UAE), Application Potential, Competitive Market Share & Forecast, 2019 - 2025’, available with Market Study Report, the global electrophysiology market is anticipated to cross USD 6.5 billion by the year 2025.
 

Rising cases of cardiovascular disorders across the globe are driving the growth of electrophysiology market. Rising geriatric population which is prone to heart related diseases is stimulating the demand for electrophysiology devices. Atrial fibrillation is the most common cause of necrosis in heart muscles which leads to irregular heartbeats. Growing number of cases associated with a high risk of heart attack is positively impacting the demand for electrophysiological monitoring devices.
 

Technological advancements and rising investments in R&D will trigger the market growth. For instance, advanced electrophysiology devices incorporate diagnostic and ablation catheters with sensors which allow physicians to remotely monitor patients, thereby, indicating high growth prospects of electrophysiology market in the coming years. On the reverse, lack of skilled electrophysiologists coupled with high cost of electrophysiological devices and high initial cost will restrain the market growth during the forecast period.
 

Based on the product type, the report cites that the electrophysiology laboratory devices segment gained a revenue share of 12.4% in 2018 and is expected to grow substantially during the study period. Prevalence of cardiovascular diseases due to an inactive lifestyle, and obesity is propelling the demand for electrophysiology laboratory devices.
 

Speaking of indication, atrial flutter segment is projected to grow with a CAGR of over 7.0% during the projected timeline. Early diagnosis with the aid of electrophysiology devices will help pinpoint the origin of atrial contraction and prevent excessive palpitations.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1294891/
 

Considering the geographical outlook, Canada electrophysiology market accounted for a revenue share of more than USD 222 million in 2018 and is projected to accrue substantial gains in the coming years. The regional growth can be attributed to presence of key players coupled with the rising number of investments in R&D activities.
 

On the other hand, Japan electrophysiology market is also expected to grow significantly with a CAGR of 5.9% during the analysis period, owing to rising cases of cardiovascular diseases, obesity and diabetes in the region. Furthermore, government initiatives and technological advancements will boost the regional outlook in the years to come.
 

Prominent players of electrophysiology market include Biotronik SE & Co. KG, Abbott Laboratories, Johnson & Johnson, Boston Scientific Corporation, and Koninklijke Philips.